Yonesaka K, Hayashi H, Nakamura A, Sato Y, et al. Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial. Clin Lung Cancer 2023 Jun 3:S1525-7304(23)00110.
PMID: 37344331